Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Five U.S. states sue Purdue Pharma over marketing, selling of opioids

Five U.S. states filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin.

Read More »

Two Pharma Companies Expand on the Coasts, Open New Facilities

With the acquisition of Shire, Takeda Pharmaceutical is building up the company’s research and development presence in the United States. Additionally, Insulet Corporation is celebrating the grand opening of the company’s new global headquarters and U.S. manufacturing facility in Acton, Mass.

Read More »

As measles returns, U.S. states look to cut vaccine exemptions

Maine could soon prohibit parents from citing religious or personal beliefs to avoid vaccinating their children, making the U.S. state one of a half dozen cracking down during the nations’ largest measles outbreak in 25 years.

Read More »

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

Drug distributor McKesson Corp. agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold the company responsible for contributing to the opioid epidemic, the state’s attorney general said.

Read More »

To Bolster Shingrix Production, GSK Invests $100 Million in Montana Manufacturing Facility

GlaxoSmithKline is investing heavily in a Montana manufacturing facility that specializes in the manufacture of the company’s two-year-old shingles vaccine Shingrix, which is eying blockbuster status.

Read More »

Kite Builds Maryland CAR-T Manufacturing Site That Could Employ up to 900

Gilead Sciences subsidiary Kite Pharma broke ground on a Maryland facility that will significantly expand the company’s ability to manufacture a variety of CAR-T therapies, including the company’s previously approved Yescarta.

Read More »

Swiss drugmaker Roche ups outlook as sales growth offsets price hit

Roche lifted the Swiss drugmaker’s 2019 outlook as sales growth in China and the United States outpaced price declines the company has suffered amid President Donald Trump’s pressure on the industry to hold down charges.

Read More »

Measles cases in U.S. surge nearly 20% in early April, CDC says

The number of confirmed cases of measles in the United States jumped by nearly 20 percent in the week ended April 11, 2019, in the country’s second-worst outbreak in nearly two decades, federal health officials reported.

Read More »

Pink Slips Continue to Hit California Life Science Companies

Charles River Laboratories and Janssen Pharmaceutical are both making cuts as they reprioritize their businesses, according to Worker Adjustment and Retraining Notifications filed with the state of California.

Read More »

Advocacy Group and FDA Advisor Call for a Moratorium on Opioid Approvals

As America continues to grapple with the opioid crisis, nonprofit advocacy group Public Citizen is calling for the U.S. Food and Drug Administration (FDA) to place a moratorium on the approval of any new opioid medications.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom